孕早期母体维生素B12与叶酸水平与妊娠期糖尿病的关联:英国前瞻性队列研究(PRiDE研究)
这项英国前瞻性多中心多民族队列研究(n=4746)探讨孕早期维生素B12和叶酸水平与孕26-28周妊娠期糖尿病(GDM)风险的关系。研究发现孕早期B12不足(42.3%)和叶酸过量(36.5%)常见;B12水平较低和叶酸水平较高与GDM风险升高相关,低B12高叶酸组合的GDM风险更高。
要点
- 孕早期B12不足和叶酸过量常见,分别占42.3%和36.5%。
- B12水平较高与IADPSG-GDM风险降低14.4%相关(RR 0.856)。
- 叶酸水平较高与IADPSG-GDM风险升高11%相关(RR 1.11)。
核心结论
- 孕早期B12不足和叶酸过量常见,低B12和高叶酸水平与母体血糖小幅但统计学显著的改变及GDM风险升高相关。
研究设计与样本
- 英国前瞻性、多中心、多民族队列研究(PRiDE研究),纳入符合NICE选择性筛查标准的孕妇4746例。
主要发现
- GDM患病率按NICE标准为12.5%,按IADPSG标准为14.7%。
- 孕早期B12不足(<220 pmol/l)占42.3%,叶酸过量占36.5%,叶酸缺乏占1.3%。
- 孕早期B12中位数较低、叶酸中位数较高的女性在孕26-28周被诊断GDM。
- B12与空腹血糖(1 SD:-0.06 mmol/l;95% CI -0.04, -0.08;p < 0.0001)和2小时血糖(-0.07 mmol/l;95% CI -0.02, -0.12;p = 0.004)呈负相关。
- 调整关键混杂因素后,B12较高与IADPSG-GDM风险降低14.4%相关(RR 0.856;95% CI 0.786, 0.933;p = 0.0004),约一半关联通过BMI介导。
关键数值与推荐
- 叶酸与2小时血糖正相关(0.08 mmol/l;95% CI 0.04, 0.13;p = 0.0005),与空腹血糖呈U型关系(二次项β:0.011;p = 0.05)。
- 调整关键混杂因素后,叶酸较高与IADPSG-GDM风险升高11%相关(RR 1.11;95% CI 1.036, 1.182;p = 0.002)。
- 低B12高叶酸组合与更高血糖水平和IADPSG-GDM风险相关(调整RR 1.742;95% CI 1.226, 2.437;p = 0.003)。
临床怎么用
- 孕早期应关注B12不足和叶酸过量,尤其低B12高叶酸组合可能提示GDM风险升高。
- B12与GDM的关联约一半通过BMI介导,提示体重管理可能部分抵消低B12的不利影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide in all ethnic groups. Low vitamin B12 and low/high folate levels may contribute to GDM risk, but there is conflicting evidence. Our aim is to assess the relationships of early pregnancy vitamin B12 and folate levels with the risk of GDM status at 26-28 weeks of gestation. METHODS: This was a prospective, multi-centre, multi-ethnic cohort study (n = 4746) in the UK. Participants who were eligible to be selectively screened as per the National Institute for Health and Care Excellence (NICE) criteria were included in the study. RESULTS: GDM prevalence was 12.5% by NICE and 14.7% by International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. Folate deficiency (1.3%) was rare but B12 insufficiency (42.3% at <220 pmol/l) and folate excess (36.5%) were common in early pregnancy. Early pregnancy median B12 levels were lower, and folate levels higher, in women who were diagnosed with GDM at 26-28 weeks. B12 was negatively associated with fasting plasma glucose (1 SD: -0.06 mmol/l; 95% CI -0.04, -0.08; p < 0.0001) and 2 h plasma glucose levels (-0.07 mmol/l; 95% CI -0.02, -0.12; p = 0.004). Higher B12 was associated with 14.4% lower RR of IADPSG-GDM (0.856; 95% CI 0.786, 0.933; p = 0.0004) after adjusting for key confounders (age, parity, smoking status, ethnicity, family history, household income and folate status). Approximately half of this association was mediated through BMI. Folate was positively associated with 2 h plasma glucose levels (0.08 mmol/l; 95% CI 0.04, 0.13; p = 0.0005) but its relationship with fasting plasma glucose was U-shaped (quadratic β: 0.011; p = 0.05). Higher folate was associated with 11% higher RR of IADPSG-GDM (adjusted RR 1.11; 95% CI 1.036, 1.182; p = 0.002) (age, parity, smoking status, ethnicity, family history, household income and B12 status). Although no interactions were observed for B12 and folate (as continuous variables) with glucose levels and GDM risk, a low B12-high folate combination was associated with higher blood glucose level and risk of IADPSG-GDM (adjusted RR 1.742; 95% CI 1.226, 2.437; p = 0.003). CONCLUSIONS/INTERPRETATION: B12 insufficiency and folate excess were common in early pregnancy. Low B12 and high folate levels in early pregnancy were associated with small but statistically significant changes in maternal blood glucose level and higher RR of GDM. Our findings warrant additional studies on the role of unmetabolised folic acid in glucose metabolism and investigating the effect of optimising early pregnancy or pre-conception B12 and folate levels on subsequent hyperglycaemia. TRIAL REGISTRATION: ClinicalTrials.gov NCT03008824.
引用
- Saravanan P, Sukumar N, Adaikalakoteswari A, et al. Association of maternal vitamin B12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study). Diabetologia. 2021. PMID: 34296321. doi:10.1007/s00125-021-05510-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。